In this issue:
AD is not associated with SARS-CoV-2 outcomes
COVID-19 severity is attenuated in patients treated with dupilumab
Comparison of cytokines in skin biopsies and tape strips
Supplemental patch testing beyond a screening series essential for patients with dermatitis
ACD is commonly concomitant with stasis dermatitis
Patch testing with the patient’s own shoes increases diagnostic yield of shoe ACD
Sexual dysfunction common in AD but improves with dupilumab therapy
FLG loss-of-function variants in Latino populations do not associate with AD
FLG mutation has minimal effect on AD disease severity
Bidirectional relationship between bullous pemphigoid and dermatitis
Please login below to download this issue (PDF)